Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Naproxcinod (HCT 3012) – COX-Inhibiting Nitric Oxide-Donator

Drug

Naproxcinod (HCT 3012)

Company/Licensee

NicOx

Therapy Class

CINOD

Product Description

COX-inhibiting nitric oxide donator

Current Indication

Treatment of acute and chronic nociceptive pain

Market Sector

Pain (analgesics/antiinflammtories)

Development Status

New Drug Application filed in the US and EU
Expand

Go Top